Cargando…
Stem cells and beta cell replacement therapy: a prospective health technology assessment study
BACKGROUND: Although current beta cell replacement therapy is effective in stabilizing glycemic control in highly selected patients with refractory type 1 diabetes, many hurdles are inherent to this and other donor-based transplantation methods. One solution could be moving to stem cell-derived tran...
Autores principales: | Wallner, Klemens, Pedroza, Rene G., Awotwe, Isaac, Piret, James M., Senior, Peter A., Shapiro, A. M. James, McCabe, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791348/ https://www.ncbi.nlm.nih.gov/pubmed/29382312 http://dx.doi.org/10.1186/s12902-018-0233-7 |
Ejemplares similares
-
Cost effectiveness and value of information analyses of islet cell transplantation in the management of ‘unstable’ type 1 diabetes mellitus
por: Wallner, Klemens, et al.
Publicado: (2016) -
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019) -
TandemHeart-Assisted Balloon Aortic Valvuloplasty for Acute Transcatheter Aortic Valve Replacement Thrombosis
por: Elison, David, et al.
Publicado: (2020) -
Stem cell approaches for diabetes: towards beta cell replacement
por: Weir, Gordon C, et al.
Publicado: (2011) -
Implementation of DNA technology.
por: McCabe, E. R.
Publicado: (1991)